Clinical endophenotypes: Implications for genetic and clinical research

Michael A. Escamilla, David C. Glahn

Research output: Chapter in Book/Report/Conference proceedingChapter


The last 100 years have witnessed an unprecedented attempt by Western medicine to combine codified diagnostic systems with empirically derived treatment to identify and palliate disorders of mood, thought, and communication. Today,most individuals suffering from afflictions of mood or thought can be reliably classified into categorical “disorders” or “diseases,” based on classification systems such as the Diagnostic and Statistical Manual for Mental Disorders (DSM) (1) or the International Classification of Diseases (ICD) (2). Yet, despite advances in illness classification and the wide variety of therapies available, persons suffering from severe mental illnesses (e.g., bipolar disorder and schizophrenia) continue to endure debilitating symptoms and experience occupational and social dysfunction accordingly (3,4). In arecent publication sponsored, in part, by the World Bank, several psychiatric disorders were listed as among the ten most disabling illnesses (5).

Original languageEnglish (US)
Title of host publicationNeurogenetics of Psychiatric Disorders
PublisherTaylor and Francis
Number of pages19
ISBN (Electronic)9781420019544
StatePublished - Jan 1 2007

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)


Dive into the research topics of 'Clinical endophenotypes: Implications for genetic and clinical research'. Together they form a unique fingerprint.

Cite this